Charles V Pollack Selected Research

Charles V Pollack Research Topics

Disease

56	Hemorrhage 01/2021 - 06/2006
55	Acute Coronary Syndrome 03/2021 - 11/2002
21	ST Elevation Myocardial Infarction 03/2021 - 01/2004
20	Myocardial Infarction 10/2020 - 03/2003
13	Unstable Angina 02/2020 - 09/2005
12	Thrombosis (Thrombus) 01/2021 - 01/2003
12	Non-ST Elevated Myocardial Infarction 12/2020 - 11/2003
12	Stroke (Strokes) 10/2020 - 11/2005
9	Heart Failure 10/2020 - 05/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2002
7	Asthma (Bronchial Asthma) 01/2016 - 08/2002
6	Atrial Fibrillation 01/2019 - 09/2013
6	Hypertension (High Blood Pressure) 10/2011 - 07/2006
5	Venous Thromboembolism 01/2019 - 11/2012
5	Ischemia 12/2009 - 12/2006
5	Chest Pain (Chest Pains) 12/2006 - 01/2004
4	Necrosis 02/2020 - 04/2005
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2020 - 09/2006
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 03/2014
4	Wounds and Injuries (Trauma) 04/2016 - 11/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 06/2011
3	Pain (Aches) 01/2021 - 01/2015
2	Acute Pain 01/2021 - 03/2016
2	Infections 01/2020 - 04/2015
2	Ischemic Stroke 04/2016 - 01/2003
2	Musculoskeletal Pain 10/2015 - 01/2015
2	Hematoma 08/2014 - 12/2009
2	Pulmonary Embolism 09/2013 - 11/2012
2	Chronic Renal Insufficiency 03/2009 - 03/2008
2	Infarction (Infarctions) 05/2007 - 12/2006
2	Renal Insufficiency (Renal Failure) 09/2006 - 07/2002
2	Bundle-Branch Block (Fascicular Block) 10/2004 - 03/2003
2	Closed Head Injuries 08/2003 - 11/2002
2	Craniocerebral Trauma (Head Injury) 08/2003 - 11/2002
1	Disease Progression 12/2020

Drug/Important Bio-Agent (IBA)

20	AnticoagulantsIBA 10/2020 - 11/2012
17	Heparin (Liquaemin)FDA LinkGeneric 03/2021 - 06/2006
14	Clopidogrel (Plavix)FDA Link 12/2020 - 01/2003
14	Dabigatran FDA Link 10/2019 - 11/2012
12	Glycoproteins (Glycoprotein)IBA 03/2012 - 07/2003
10	TroponinIBA 02/2020 - 07/2002
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2003
9	idarucizumabIBA 01/2019 - 07/2015
8	Vitamin K FDA Link 01/2020 - 08/2014
8	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017 - 10/2006
7	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2006
7	Platelet Membrane Glycoprotein IIbIBA 08/2009 - 07/2003
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016 - 06/2006
6	bivalirudin (Angiomax)FDA Link 08/2009 - 04/2008
5	otamixabanIBA 03/2021 - 12/2012
5	AntithrombinsIBA 09/2013 - 10/2006
4	Eptifibatide (Integrilin)FDA Link 03/2021 - 12/2012
4	TicagrelorIBA 12/2020 - 11/2010
4	Pharmaceutical PreparationsIBA 03/2016 - 10/2004
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 09/2013
4	RivaroxabanIBA 01/2016 - 11/2012
3	Oxygen (Dioxygen)IBA 02/2020 - 03/2003
3	trans-crotonin (CTN)IBA 02/2020 - 12/2006
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 09/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012 - 08/2002
3	clevidipine FDA Link 04/2011 - 03/2009
2	Troleandomycin (TAO)FDA Link 03/2021 - 09/2013
2	Prasugrel Hydrochloride FDA Link 12/2020 - 02/2020
2	Complement System Proteins (Complement)IBA 09/2020 - 04/2009
2	Adenosine Diphosphate (ADP)IBA 02/2020 - 08/2009
2	prothrombin complex concentrates (PPSB)IBA 01/2020 - 08/2014
2	apixabanIBA 01/2018 - 09/2016
2	Purinergic P2Y Receptor AntagonistsIBA 06/2017 - 01/2003
2	Opioid Analgesics (Opioids)IBA 03/2016 - 10/2015
2	Analgesics (Analgesic Drugs)IBA 03/2016 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 03/2014 - 06/2013
2	Factor Xa InhibitorsIBA 09/2013 - 05/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2010 - 07/2006
2	LipidsIBA 12/2010 - 07/2005
2	cangrelorIBA 12/2009 - 12/2009
2	Fondaparinux (Arixtra)FDA Link 06/2009 - 05/2008
2	helioxIBA 11/2008 - 03/2003
2	HeliumIBA 11/2008 - 03/2003
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2008 - 01/2004
2	Indicators and Reagents (Reagents)IBA 08/2007 - 01/2006
2	MB Form Creatine KinaseIBA 01/2006 - 01/2004
2	NexusIBA 08/2003 - 11/2002
2	Troponin T (Troponin T1)IBA 03/2003 - 07/2002
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2020
1	omega-Chloroacetophenone (Mace)IBA 02/2020

Therapy/Procedure

54	Therapeutics 01/2021 - 08/2002
17	Percutaneous Coronary Intervention 03/2021 - 03/2003
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2020 - 03/2003
4	Stents 12/2020 - 12/2009
3	Anticoagulation Reversal 10/2020 - 05/2017
3	Thrombolytic Therapy 01/2006 - 01/2004
2	Length of Stay 12/2020 - 11/2007
2	Electric Countershock (Cardioversion) 01/2018 - 09/2016
2	Analgesia 03/2016 - 01/2015
2	Catheters 06/2011 - 06/2009
2	Contraindications 05/2010 - 07/2005
1	Pain Management 01/2021
1	Secondary Prevention 01/2021
1	Extracorporeal Membrane Oxygenation 09/2020